A method and an apparatus for determining analytical data concerning the inside of a scattering matrix, in particular of a biological sample. In a detection step detection measurements are carried out in which light is irradiated into the matrix as primary light at an irradiation site (12) through an interface bounding the scattering matrix (6) and light emerging out of the scattering matrix through the interface is detected as secondary light at a detection site (13) at a predetermined measuring distance from the irradiation site, in order to determine as a measurement variable a measurable physical property of the light which varies due to the interaction of the light with the scattering matrix, which measurement variable is a measure of the analytical data to be determined. In an evaluation step the analytical data are determined on the basis of the measurement variable measured in the detection step. In order that such a matrix analysis may be carried out with relatively simple measuring means, at least two detection measurements are carried out in the detection step with different reflection conditions at the interface (5) between the irradiation site (12) and the detection site (13), in each of which the measurement value of the measurement variable is determined.
|
18. An apparatus for determining analytical data of a light scattering matrix, said apparatus comprising:
a measuring head, said measuring head including a sample contact surface for contacting an interface of the biological sample; light irradiation means disposed in said measuring head for irradiating light into the biological sample at an irradiation site through an irradiation opening in the sample contact surface, detection means connected to said measuring head for detecting secondary light emerging from the scattering matrix at a detection site through a detection opening in the sample contact surface; evaluation means connected to said light irradiation means and said detection means for determining analytical data based upon the primary light and the secondary light, wherein said sample contact surface includes reflection adjustment means wherein different reflection conditions can be provided in at least two detection measurements.
1. A method for determining analytical data regarding a light scattering matrix, said method comprising the steps of:
detecting secondary light by irradiating light into the scattering matrix as primary light at an irradiation site through an interface bounding the scattering matrix, and detecting light emerging out of the scattering matrix through the interface, said emerging light being detected as secondary light at a detection site which is located at a predetermined measuring distance from the irradiation site; determining a measurement value of a measurable physical property of the secondary light, said measurable physical property varying due to an interaction of the primary light with the scattering matrix; evaluating the measurement value as a measure of the analytical data to be determined, the analytical data being determined based upon a measurement value of the measurement variable, wherein at least two of said detecting steps are carried out under different reflection conditions at the interface between the irradiation site and the detection site, and measurement values determined in said at least two detection steps are evaluated in said evaluation step to determine said analytical data.
2. A method according to
3. A method according to
4. A method according to
5. A method according to
6. A method according to
7. A method according to
8. A method according to
9. A method according to
10. A method according to
12. A method according to
13. A method according to
14. A method according to
16. A method according to
19. An apparatus according to
20. An apparatus according to
21. An apparatus according to
|
The invention relates to a method and an apparatus for determining analytical data concerning the inside of a scattering matrix, in particular of a biological sample, with the aid of light.
The most important case of the application of the invention is the investigation of biological samples, in particular of the tissue of a living organism. Biological samples are in most cases optically heterogeneous, i.e. they contain a large number of scattering centers at which irradiated light is scattered. This applies to human or animal tissue, in particular skin tissue or subcutaneous fatty tissue, but also to fluid biological samples, such as blood for example, in which the blood corpuscles form scattering centers, or else to milk, in which the scattering centers are formed by emulsified fat droplets. In addition the invention is directed towards scattering matrices in general, in the sense that three-dimensional structures are involved which have such a high density of optical scattering centers that irradiated light is generally scattered many times before it leaves the scattering matrix. Scattering matrices with a mean free path length of the light of less than 5 mm are mainly involved. Non-biological scattering matrices which can be investigated on the basis of the present invention are for example emulsions and dispersions, such as are required for various applications, for example for paints and dyes as well as for surface coatings of plastics materials.
It is also possible for analytical data to be determined by means of the present invention on fluids which do not themselves contain any scattering centers, if the fluids are allowed to flow through a container in which light-scattering particles with preferably known scatter properties are located. In this case the contents of the container (fluid with scattering centers) form a scattering matrix in the sense of the invention. This method can in particular be useful in cases where the desired analytical data on the clear fluid cannot be determined satisfactorily with other methods (for example spectroscopically).
The invention relates to the determination of analytical data which can be determined from the interaction of irradiated light with the matrix ("optical analytical data"). In a "detection step" of such a method, measurements are performed in which light is irradiated with the aid of irradiation means at an irradiation site through an interface bounding the matrix, and at the same time light emerging through the same interface (i.e. "in reflection") is detected at a detection site with the aid of detection means at a predetermined measuring distance from the irradiation site. Such a measuring operation will be referred to below as detection measurement, the irradiated light as primary light and the detected light as secondary light.
In such detection measurements a measurable physical property of the light is determined, which can be described as a "quantifiable parameter" and which will for the sake of simplicity be referred to below as the "measurement variable". The measurement variable is in most cases the intensity of the secondary light, which is frequently measured as a function of the light wavelength. In addition other measurement variables, such as for example the polarizing direction and the degree of polarization of the secondary light (where the primary light is polarized), as well as the phase of the secondary light (where the primary light is irradiated intensity-modulated) are also used to obtain optical analytical data.
From the measurement values of the detection measurements performed in the detection step there can be determined in a subsequent evaluation step, by means of an evaluation algorithm, various analytical data which are dependent on the interaction of the light with the scattering matrix. This refers in particular to parameters which describe quantitatively the optical properties of the scattering matrix, such as the scattering coefficient μs, the absorption coefficient μa, the anisotropy factor of the scattering g and the refractive index n. Such parameters will be referred to below as "light transport parameters".
In the investigation of biological samples the determination of the concentration of substances contained in the sample, such as for example water, glucose, bilirubin, cholesterol, triglycerides, urea, uric acid, oxyhaemoglobin, haemoglobin or cytochromeoxidase, is of main interest. The concentration of analytes of this kind is as a rule determined invasively, i.e. after removal of a blood sample from the living organism. There has long been a desire to replace this invasive analysis by a pain-free, non-invasive analysis.
There is moreover a close connection between the light transport parameters (in particular μa and μs) and the chemical analysis of substances. The latter is based as a rule on spectroscopic principles, i.e. on the investigation of the spectral dependence of the optical absorption. Whereas this is a long established, problem-free method in a clear fluid, there is in biological samples, because of the multiple scattering of the light, the problem that the optical path length of the light in the sample is unknown. If it becomes possible, by means of a suitable measurement method, to determine the optical absorption separately from the scattering (i.e. to separate μa from μs), this problem is solved and the known spectroscopic principles can be used for the analysis of numerous substances in biological samples.
Optical analytical data of scattering matrices are therefore of significance for quite different applications. Methods for determining such data will be referred to here collectively as "optical matrix analysis". Optical matrix analysis embraces in particular the investigation of scattering matrices with respect to their light transport parameters and analytical data derivable therefrom.
In connection with the separate determination of analytical data which on the one hand describe the scatter characteristics and on the other the absorption characteristics of light in a scattering medium, the determination of μa and μs from the dependence I(d) of the intensity I of the secondary light on the measuring distance d is discussed. Diffusion theory and numerical-statistical methods (Monte Carlo calculations) form the theoretical basis of this discussion. Reference can be made in this context to the following publications, which are incorporated herein by reference, as non-essential background information:
M. Keijzer et al.: "Optical diffusion in layered media", App. Opt. 27, 1820-1824 (1988);
S. T. Flock et al.: "Monte Carlo modeling of light propagation in highly scattering tissue--I: Model predictions and comparison with diffusion theory", IEEE Trans. Biomed. Eng., 36, 1162-1168 (1989);
T. J. Farrell et al.: "A diffusion theory model of spatially resolved, steady-state diffuse reflectance for the non-invasive determination of tissue optical properties in vivo", Med. Phys., 19, 879-888 (1992).
Although a good agreement of measurement values and theoretical calculations is reported, these methods have not acquired any practical importance, in particular for the determination of analytes in biological samples.
Recently also so-called frequency-domain measuring methods are in discussion. These operate with light modulated at high frequency and therefore call for highly sophisticated measuring equipment.
The invention refers to the problem of improving the optical matrix analysis, in particular as regards the measuring equipment required.
The problem is solved, in a method in which a detection step with detection measurements and an evaluation step of the kind described are carried out, by the fact that in the detection step at least two detection measurements are carried out with different reflection conditions at the interface between the irradiation site and the detection site, in each of which a measurement value of the measurement variable is determined. Each of the quantifiable parameters of the light which were discussed above is considered as a measurement variable, i.e. the intensity of the light as well as the degree of polarization, the polarizing direction and the phase position.
In the context of the invention it has been found that improved optical matrix analysis--in particular an improved separation of the influences of scattering and absorption--is possible if the method is devised in such a way that the reflectivity at the interface between matrix and environment is changed and a new independent externally adjustable variable is thereby introduced. The reflectance behavior can be influenced in various ways. It is only important that photons which on their path from the irradiation site to the detection site arrive at the interface are reflected back into the matrix with differing probability in the two detection measurements. In other words, the possibility that photons leave the matrix at the interface is to be significantly different in the two detection measurements. The light intensity escaping through the interface (with unchanged matrix) is to differ significantly (as a rule by at least 10%) in the two measurements.
The wavelength of the test light can be selected in a wide range between the UV and the infrared (somewhere between 200 nm and 3 μm). The term light in the sense of the invention is therefore not restricted to the visible spectral region.
By the measuring method according to the invention inter alia the following advantages are achieved:
It is sufficient to determine only the DC intensity of the secondary light. High frequency measurements are not necessary.
Generally relative measurements of the intensity, i.e. measurement of the ratio of the intensity of the secondary light in the two detection measurements, each with different reflectance behavior, are sufficient.
The influences of optical absorption and scattering can be separated.
The dependence of the measured signal on the one hand on the scattering characteristics and on the other on the absorption characteristics of the scattering matrix differs to such an extent that it is in many cases not even necessary to use complicated evaluation methods to calculate the scattering and absorption coefficients.
The invention is directed in particular towards the following aspects of matrix analysis:
Determination of light transport parameters, in particular of an absorption parameter which is a measure of the absorption of the light in the scattering matrix and/or of a scattering parameter which is a measure of the scattering of the light in the scattering matrix. The terms "absorption parameter" and "scattering parameter" refer here to quantities which describe the optical absorption or the light scattering independently of one another. In practice, the absorption is generally described by μa and the scattering by the modified scattering coefficient μs '=μs (1-g), where g is the scattering anisotropy factor.
Determination of the concentration of a substance in the biological sample. Examples of analytes have already been given.
The light transport properties of a scattering matrix are influenced by the substances contained therein in different ways. This applies not only to the optical absorption, the wavelength-dependence of which is conventionally used for the spectroscopic analysis. In many cases the other light transport parameters, in particular the scattering coefficient and the refractive index, are also influenced by the concentration of particular substances in the sample, this phenomenon also being wavelength-dependent. Optical analytical data concerning the light transport parameters in a scattering matrix therefore form a basis for the analysis of substances contained therein.
Changes in concentration lead to characteristic changes in the light transport parameters, which can be determined at one or more wavelengths and be correlated with the concentration of the substance to be analyzed. It is possible to proceed in such a way that one or more of the above-mentioned light transport parameters are explicitly determined and a correlation with the desired analyte concentration by means of a calibration. In many cases it is preferable, however, to make a direct correlation between the measured measurement values of the measurement variable and the analyte concentration (by calibration).
As is known, the reflectance behavior at optical interfaces is dependent on the ratio of the refractive indices at the reflecting interface. If the refractive index na outside is smaller than the refractive index ni inside the scattering matrix, total reflection is obtained if the angle of incidence is small enough. Biological samples have generally a refractive index of significantly more than 1 (typically of about 1.5). If air is contained in the outside area (na =1), a large percentage of the photons which reach the interface between irradiation site and detection site are reflected. This reflection is reduced if a substance with a higher refractive index is applied to the interface, for example a gel, whose refractive index corresponds approximately to that of the matrix. In this case photons which reach the interface pass over with high probability into the gel. If the gel (or another substance with a corresponding refractive index) is dark coloured, the photons are absorbed therein, so that they do not pass back into the matrix. A first possibility for influencing the reflectance behavior at the interface therefore is to contact the interface in the intermediate region between irradiation site and detection site during the two detection measurements with substances of different refractive index. This possibility will be referred to as "refractive index embodiment" below.
More practical and therefore preferred, is the possibility to arrange at the interface between irradiation site and detection site reflective surfaces with different reflectivities. For example, in a first detection measurement an optically highly absorbent surface can be arranged (as "contact surface") between the irradiation site and the detection site in contact with the interface of the matrix, while in a second detection measurement a highly reflective contact surface is located between the irradiation site and the detection site ("contact surface embodiment"). Various possibilities for realizing such arrangements will be described in detail by means of the figures.
The invention will be explained in more detail below by means of the figures, where
FIG. 1 shows a unit suitable for the invention in a diagrammatic representation partly in cross-section and partly as a block diagram;
FIGS. 2, 3 and 4 show various embodiments of the sample contact plate of a measuring head suitable for the invention;
FIG. 5 shows a graph of the dependence on the measuring distance of the quotient Q of the intensity of the secondary light during detection measurements with two different reflection conditions;
FIG. 6 a graph of the fractional change of Q for each 1% change in the absorption coefficient and the scattering coefficient and
FIG. 7 the change of Q as a function of the chain in the absorption coefficient and the scattering coefficient for two different measuring distances.
The apparatus for the optical analysis of scattering matrices which is shown in highly diagrammatic form in FIG. 1 consists essentially of a measuring head 1 and a signal processing and analyzing unit 2.
The measuring head 1 is in contact with an interface 5 of the scattering matrix 6 to be investigated via the sample contact surface 3 of a sample contact plate 4. It contains light irradiation means 8, which in the case shown are formed by a light emitting diode 9 positioned in a recess in the sample contact plate 4 and irradiate light into the matrix 6 through an irradiation opening 14 in the sample contact surface 3, said irradiation opening 14 being formed in this case by the recess in the sample contact plate 4. The detection means 10 include in the embodiment shown a light-conducting fiber 11, which detects the light escaping at a detection site 13 through a detection opening 15 in the sample contact surface 3. The detected light is fed to a photo-receiver 16 (for example an avalanche-type photodiode) arranged in the signal processing unit 19 of the signal processing and analyzing instrument 2. The output signal of the photo-receiver 16 is amplified by an amplifier 17 and coupled to an analyzing unit 18, in which it is processed--preferably digitally by means of a microcomputer--to the desired analytical data.
In the analyzing unit 18 conventional electronic methods are employed for the exact and selective detection of the measurement variable of the light. The use of comparators is conventional for relative measurements. For the elimination of interference the use of pulsed or modulated primary light, in conjunction with a corresponding frequency-selective measuring method (lock-in method), is advantageous.
To this extent the apparatus shown is conventional and therefore does not have to be explained in greater detail. Details on possible designs and different configurations of the measuring head can be taken from the published state of the art. Reference may be made, for example, to WO 94/10901, in which several different arrangements and designs of the light irradiation means and the detection means are described. In particular both the irradiation means and the detection means can be realized in the form of light transmitters or light-sensitive elements integrated directly into the sample contact plate 4 (such as the light transmitter 9 in the present case), or by means of light-conducting fibers which lead the light up to the skin contact plate 4 from a more distant light transmitter or (as in the case shown) transmit it from the detection site 13 to a more distant light receiver.
A significant difference compared with the previously known units consists in the fact that the sample contact surface 3 resting against the interface 5 of the matrix 6 is equipped with means by means of which, in at least two detection measurements, different reflection conditions are caused between the respective irradiation site 12 and the respective detection site 13 ("reflection adjustment means"). This can be realized in different embodiments. Sample contact plates 4 representing differing embodiments are shown in FIGS. 2 to 4. The critical factor is the sample contact surface 3 making contact with the matrix 6. The element which carries the sample contact surface 3 does not necessarily have to be formed as a (flat) plate.
In the embodiment shown in FIG. 2 the reflection adjustment means are provided by a sample contact surface 3 with variable reflection properties. An LCD or a ferroelectric display is suitable. These electronic components are commercially available in particular for display purposes, wherein the area of the display is sub-divided into sections whose light reflection properties can be changed by means of electric control signals. In the context of the invention mainly the intermediate area marked as 20 in FIG. 2, namely that between the irradiation opening 14 and the detection opening 15, is to be variable in its reflection properties. The form of the sub-area of the sample contact area 3, which has different reflection properties during the at least two detection measurements, can vary.
The embodiment shown in FIG. 2, with a sample contact surface 3 with adjustable reflection properties, can be used in units (as shown) in which the light is irradiated at only one single irradiation site 12 and detected at only one single detection site 13. This embodiment causes, however, a certain structural complexity and the required electrical activation leads to an (albeit small) energy consumption.
A reduction in this complexity is possible if in the at least two detection measurements of a detection step the light is irradiated at two different irradiation sites and/or detected at two different detection sites, so that different sections of the interface lie between irradiation site and detection site in each case, wherein the reflectance behavior of the contact surface varies in the different sections.
An embodiment of this kind is shown in FIG. 3. In this case the light is irradiated through a light irradiation opening 14 and detected through two detection openings 15a and 15b arranged at the same distance from, but on opposite sides of, the irradiation opening 14. In this case the section of the sample contact area 3 which lies between the irradiation site 12 and the two detection sites 13a and 13b marked by the detection openings 15a and 15b (intermediate area) is different. The intermediate areas 25a, 25b possess strongly different reflection properties, for example the intermediate area 25a can be metallically reflective, so that it acts as a virtually total photon reflector, while the intermediate area 25b is matt black and consequently acts as a photon trap. In such an embodiment the reflection adjustment means are therefore formed by the sections of the sample contact area 3 with different reflectivity in combination with the recesses suitably arranged therein at the irradiation and detection sites.
In the embodiment shown the irradiation sites and detection sites are of longitudinal shape. This permits a good local resolution with relatively high intensity of the light, as is explained in detail in WO 94/10901. Different configurations of the detection sites and the irradiation sites, such as those known from the known state of the art, can be used in the invention.
The embodiment shown in FIG. 3 can also be modified inasmuch as several irradiation sites and one detection site can be used. It is naturally also possible, by means of a multiplicity of irradiation sites and a multiplicity of detection sites, to adjust different light paths in different sections of the matrix to be investigated and in different spatial directions, as is likewise described in WO 94/10901. It is critical in the context of the invention, however, that several detection measurements with different reflection conditions between the respective irradiation site and the respective detection site, but preferably at the same measuring distance, must be possible.
FIG. 4 shows a variant with one irradiation site 12 and in each case two different detection sites 13a,b; 13c,d; 13e,f and 13g,h. In this embodiment two different measuring distances can be set in four spatial directions in each case between the irradiation site and the respective detection site. The intermediate areas also in this case have different reflectivity, wherein preferably opposite intermediate regions (e.g. 25a, 25e and 25c, 25g) have identical reflection properties.
FIG. 5 shows experimental results which were obtained with an experimental model of a scattering matrix, the optical properties of which correspond essentially to those of human skin tissue. It consisted of a cuboid with the dimensions 8 cm×8 cm×20 cm, an absorption index of μa =0.02 mm-1, a modified scattering index of μs '=0.9 mm-1 and a refractive index on the inside of the matrix of ni =1.56 at a wavelength of light of L=780 nm. The light was irradiated and detected at the interface of the experimental model of two optical fibers with a core diameter of 100 μm, which were positioned at fixed measuring distances of d=4 mm and d=6.5 mm.
The reflection properties in the intermediate area between irradiation site and detection site were varied by changing the refractive index na. A first series of measurements was carried out with air (na =1) in the outside area at the interface between the irradiation site and the detection site. In a second series of detection measurements the interface was covered with a gel with a refractive index of na =1.46. It was mixed with a black colour in order to absorb practically all of the light which had penetrated into the gel.
The refractive index ratio ns =ni /na determines in known manner the reflection properties at the interface, which are also referred to as boundary conditions in technical language. With the experimental conditions described two different boundary conditions ns1 =1.56 and ns2 =1.07 can be set. The term ns will be used throughout below for the reflection properties (boundary conditions) in the intermediate area between irradiation site and detection site, i.e. irrespective of whether the various reflection conditions are realized (as in the experimental model described) by the refractive index embodiment or, as in FIGS. 2 to 4, by the contact surface embodiment.
In the graph of FIG. 5 there is plotted on the ordinate the quotient Q of the intensity I of the secondary light for detection measurements with two different boundary conditions ns :
Q(ns1,ns2)=I(ns1)/I(ns2)
This measurement variable is shown in its dependence on the measuring distance d, wherein the experimental results are marked as dots.
The continuous curve represents calculations obtained by diffusion theory (equation (18) of the above-mentioned article by T. J. Farrell et al.). This describes the dependence of the diffuse reflection on the measuring distance d under given optical conditions R(d)|μa, μs ',ns. From this one gets ##EQU1##
An astonishingly good agreement between experiment and theory is obtained, in particular considering that no normalization of any kind was made. The experimental dots were simply corrected by a factor of F=2.43, in order to allow for the fact that no gel was applied at the contact surface of the light-conducting fibers with the interface and hence also no change in the refractive index was present in this partial area of the interface, whereas in Farrell's theory a uniform refractive index across the entire interface is assumed. The factor F=S(ns1)/S(ns2) is obtained from the ratio--determined by ns1 and ns2 --of the segments S of the matrix, from which segments light can emerge and be collected by the detector fiber: S(n2)≈3-2cosθ-cos2 θ, where θ≈sin-1 (1/ns).
The light transport parameters and other optical analytical data associated with them can be determined in various ways on the basis of the explanations given here and the experimental results shown.
Preferably in the evaluation step first a ratio Q of intensity measurement values for the at least two measurements with different reflection conditions is calculated. If Q, as shown in FIG. 5, is determined as a function of the measuring distance d for several measuring distances, the coefficients μa and μs ' can be determined separately by fitting the above-mentioned diffusion theory equations to the experimental results. Alternatively it is possible to measure for a measuring distance d a plurality of relationships Qi for different nsi 's. This also allows separation of μa and μs '. In general at least two detection measurements with different boundary surface conditions nsi are preferably carried out for at least two measuring distances di in each case.
As already mentioned, the algorithm for determining the desired analytical data on the basis of the measurement variable measured in the detection step can also be purely empirical. An increasing number of numerical correlation methods have recently been used in chemical analysis, in order to form a correlation between the measurement variables (input variables) and the analytical data sought (output variables) based on a calibration with samples for which the data to be analyzed are known. The latter include iterative methods for the optimal description of the relationship of input variables and output variables, as well as multilinear and non-linear algorithms. Neural networks are also used for this purpose.
In the present invention the skilled person can use such numerical methods on the basis of the explanations given here, wherein a relationship Q does not necessarily have to be formed. Instead, measurement values I(ns)|di of the measurement variable which have been measured as a function of the boundary conditions can be used directly as input variables of an evaluation algorithm. This can take place for one measuring distance d or for several measuring distances di. In the case of only one measuring distance d preferably at least three values of I are measured for three different values of ns.
FIG. 6 shows a graph of the fractional change δQ of Q for a one per cent change in the absorption coefficient and in the scattering coefficient. The curves were calculated on the basis of the above-mentioned equation of diffusion theory, wherein μa =0.01 mm-1 and μs '=1 mm-1 have been assumed for the optical properties. Three different values ns =1.0; 1.4 and 1.6 were used for the boundary conditions.
In FIG. 6 the change δQ (μa, μs ') per fractional change δμa =-1% or δμs '=-1% is plotted as a function of the distance d. It is seen that Q shows a very much higher dependence on the modified scattering coefficient μs ' than on the absorption coefficient μa. Particularly in the central range of the measuring distances between about 2 mm and about 12 to 15 mm the sensitivity of the measuring method for changes in the scattering coefficient is particularly high, i.e. the scattering coefficient can be determined with particularly good accuracy in this preferred measuring distance range.
On the basis of these results the present invention is in particular suitable for the quantitative analysis of the optical scattering properties of biological samples and other scattering matrices. According to WO 94/10901 the scattering properties of the multiple scattering of light in such samples is dependent to an astonishingly high extent on the concentration of glucose in the sample. The present invention is therefore suitable in particular for the analysis of glucose with the use of the principles explained in WO 94/10901.
In order to permit a better comparison of the dependence of Q on changes in the scattering and absorption, Q was calculated as a function of μs ' and μa for measuring distances d=5 mm and d=10 mm. This dependence is shown in FIG. 7 (for ns2 =1.4, ns1 =1.0) in a variation range of μs ' and μa of ±20%. The change as a function of μs ' is ten to fifteen times as high as the change as a function of the absorption. At the same time it is remarkable that the dependence coincides to a large extent for the two measuring distances measured.
Boecker, Dirk, Kohl, Matthias, Cope, Mark, Essenpreis, Matthias
Patent | Priority | Assignee | Title |
10007759, | Oct 31 2006 | Abbott Diabetes Care Inc. | Infusion devices and methods |
10039881, | Dec 31 2002 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
10178954, | May 08 2007 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
10201301, | Nov 01 2005 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
10201302, | Jan 27 2014 | Covidien LP | Systems and methods for determining whether regional oximetry sensors are properly positioned |
10206611, | May 17 2005 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
10213550, | Jan 23 2014 | Covidien LP | Systems and methods for monitoring clinical procedures using regional blood oxygen saturation |
10231654, | Nov 01 2005 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
10328202, | Feb 04 2015 | Covidien LP | Methods and systems for determining fluid administration |
10349874, | Sep 29 2009 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
10429250, | Aug 31 2009 | Abbott Diabetes Care Inc | Analyte monitoring system and methods for managing power and noise |
10478108, | Apr 19 2007 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
10605811, | Jun 29 2007 | ASPIRA WOMEN S HEALTH INC | Predictive biomarkers for ovarian cancer |
10653317, | May 08 2007 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
10750952, | Dec 31 2002 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
10872102, | Jul 23 2009 | Abbott Diabetes Care Inc. | Real time management of data relating to physiological control of glucose levels |
10952611, | May 08 2007 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
10952652, | Nov 01 2005 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
11043300, | Oct 31 2006 | Abbott Diabetes Care Inc. | Infusion devices and methods |
11045147, | Aug 31 2009 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
11103165, | Nov 01 2005 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
11150145, | Aug 31 2009 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
11272867, | Nov 01 2005 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
11363975, | Nov 01 2005 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
11399748, | Nov 01 2005 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
11471075, | Nov 01 2005 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
11508476, | Oct 31 2006 | Abbott Diabetes Care, Inc. | Infusion devices and methods |
11538580, | Nov 04 2005 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
11612363, | Sep 17 2012 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
11635332, | Aug 31 2009 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
11696684, | May 08 2007 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
11793936, | May 29 2009 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
11837358, | Oct 31 2006 | Abbott Diabetes Care Inc. | Infusion devices and methods |
11872370, | May 29 2009 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
11911151, | Nov 01 2005 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
6138046, | Apr 20 1999 | Miravant Medical Technologies, Inc. | Dosimetry probe |
6229589, | Oct 01 1997 | SANYO ELECTRIC CO , LTD | Liquid crystal display including a vertically aligned liquid crystal layer disposed between pixel electrodes and a common electrode |
6407794, | Oct 01 1997 | Sanyo Electric Co., Ltd. | Vertically aligned type liquid crystal display |
6418339, | May 26 1997 | Method and apparatus for determining the lines of optimal direction for surgical cuts in the human skin | |
6678541, | Oct 28 1998 | DEPARTMENT OF HEALTH AND HUMAN SERVICES, THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY | Optical fiber probe and methods for measuring optical properties |
6847835, | Mar 31 1999 | Minolta Co., Ltd. | Transcutaneous bilirubin concentration measuring apparatus and a measurement data checking plate for use with the same |
7133710, | Mar 08 2002 | GLT ACQUISITION CORP | Compact apparatus for noninvasive measurement of glucose through near-infrared spectroscopy |
7142904, | Mar 08 2001 | Magstim Group, Incorporated | Method and composition for probing the body through the skin |
7206623, | May 02 2000 | GLT ACQUISITION CORP | Optical sampling interface system for in vivo measurement of tissue |
7233816, | Aug 14 1997 | GLT ACQUISITION CORP | Optical sampling interface system for in vivo measurement of tissue |
7299080, | Jun 15 2000 | GLT ACQUISITION CORP | Compact apparatus for noninvasive measurement of glucose through near-infrared spectroscopy |
7315752, | Dec 22 2001 | Roche Diabetes Care, Inc | Method and device for determining a light transport parameter in a biological matrix |
7317938, | Oct 08 1999 | GLT ACQUISITION CORP | Method of adapting in-vitro models to aid in noninvasive glucose determination |
7333895, | Jul 29 2002 | VERMILLION, INC | Quality assurance for high-throughput bioassay methods |
7336358, | Feb 24 2003 | AUGUST NINTH ANALYSES, INC | Method and apparatus for determining particle size and composition of mixtures |
7377904, | Apr 16 2004 | GE HFS, LLC | Cap displacement mechanism for lancing device and multi-lancet cartridge |
7383069, | May 02 2000 | GLT ACQUISITION CORP | Method of sample control and calibration adjustment for use with a noninvasive analyzer |
7477393, | Sep 20 2005 | FUJIFILM Corporation | Specimen analysis system obtaining characteristic of specimen by diffusion approximation |
7499891, | Jun 19 2000 | VERMILLION, INC | Heuristic method of classification |
7519406, | Apr 28 2004 | GLT ACQUISITION CORP | Noninvasive analyzer sample probe interface method and apparatus |
7565249, | Mar 06 2001 | Roche Diabetes Care, Inc | Method for the determination of a light transport parameter in a biological matrix |
7599065, | Sep 20 2005 | FUJIFILM Corporation | Specimen analysis system obtaining characteristic of specimen by diffusion approximation |
7606608, | Dec 08 2004 | GLT ACQUISITION CORP | Optical sampling interface system for in-vivo measurement of tissue |
7620438, | Mar 31 2006 | ABBOTT DIABETES CARE, INC | Method and system for powering an electronic device |
7679407, | Apr 28 2003 | Abbott Diabetes Care Inc | Method and apparatus for providing peak detection circuitry for data communication systems |
7697966, | Feb 25 2005 | GLT ACQUISITION CORP | Noninvasive targeting system method and apparatus |
7756561, | Sep 30 2005 | ABBOTT DIABETES CARE, INC | Method and apparatus for providing rechargeable power in data monitoring and management systems |
7766829, | Nov 04 2005 | ABBOTT DIABETES CARE, INC | Method and system for providing basal profile modification in analyte monitoring and management systems |
7768408, | May 17 2005 | ABBOTT DIABETES CARE, INC | Method and system for providing data management in data monitoring system |
7787924, | Mar 08 2002 | GLT ACQUISITION CORP | Compact apparatus for noninvasive measurement of glucose through near-infrared spectroscopy |
7796254, | Feb 24 2003 | August Ninth Analyses, Inc. | Method and apparatus for determining particle size and composition of mixtures |
7811231, | Dec 31 2002 | Abbott Diabetes Care Inc | Continuous glucose monitoring system and methods of use |
7837633, | Jun 30 2004 | GE HFS, LLC | Lancing device and multi-lancet cartridge |
7860544, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
7869853, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
7884729, | May 17 2005 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
7884933, | May 05 2010 | Revolutionary Business Concepts, Inc. | Apparatus and method for determining analyte concentrations |
7885699, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
7899510, | Sep 29 2005 | Covidien LP | Medical sensor and technique for using the same |
7920907, | Jun 07 2006 | ABBOTT DIABETES CARE, INC | Analyte monitoring system and method |
7922458, | Oct 09 2002 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
7928850, | May 08 2007 | ABBOTT DIABETES CARE, INC | Analyte monitoring system and methods |
7976778, | Apr 02 2001 | Abbott Diabetes Care Inc | Blood glucose tracking apparatus |
7993108, | Oct 09 2002 | Abbott Diabetes Care Inc | Variable volume, shape memory actuated insulin dispensing pump |
7993109, | Oct 09 2002 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
8029245, | Oct 09 2002 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
8029250, | Oct 09 2002 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
8029459, | Mar 21 2005 | Abbott Diabetes Care Inc. | Method and system for providing integrated medication infusion and analyte monitoring system |
8029460, | Mar 21 2005 | Abbott Diabetes Care Inc. | Method and system for providing integrated medication infusion and analyte monitoring system |
8047811, | Oct 09 2002 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
8047812, | Oct 09 2002 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
8066639, | Jun 10 2003 | Abbott Diabetes Care Inc | Glucose measuring device for use in personal area network |
8089363, | May 17 2005 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
8103456, | Jan 29 2009 | ABBOTT DIABETES CARE, INC | Method and device for early signal attenuation detection using blood glucose measurements |
8112138, | Jun 03 2005 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
8112240, | Apr 29 2005 | Abbott Diabetes Care Inc | Method and apparatus for providing leak detection in data monitoring and management systems |
8123686, | Mar 01 2007 | ABBOTT DIABETES CARE, INC | Method and apparatus for providing rolling data in communication systems |
8149117, | May 08 2007 | Abbott Diabetes Care Inc | Analyte monitoring system and methods |
8162829, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8162830, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8175673, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8177716, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8187183, | Dec 31 2002 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
8199322, | Aug 20 2010 | Revolutionary Business Concepts, Inc. | Apparatus and method for determining analyte concentrations |
8221332, | Nov 12 2003 | GE HFS, LLC | Multi-lancet cartridge and lancing device |
8224413, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8226555, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8226557, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8226558, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8226891, | Mar 31 2006 | ABBOTT DIABETES CARE, INC | Analyte monitoring devices and methods therefor |
8231532, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8235896, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8236242, | Apr 02 2001 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus and methods |
8255031, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8260392, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8265726, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8268243, | Apr 02 2001 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus and methods |
8273022, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8275439, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8287454, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8298255, | Apr 16 2004 | GE HFS, LLC | Cap displacement mechanism for lancing device and multi-lancet cartridge |
8306598, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8343092, | Mar 21 2005 | Abbott Diabetes Care Inc. | Method and system for providing integrated medication infusion and analyte monitoring system |
8343093, | Oct 09 2002 | Abbott Diabetes Care Inc. | Fluid delivery device with autocalibration |
8344966, | Jan 31 2006 | ABBOTT DIABETES CARE, INC | Method and system for providing a fault tolerant display unit in an electronic device |
8346336, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8346337, | Nov 05 2007 | Abbott Diabetes Care Inc | Analyte monitoring device and methods of use |
8353829, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8357091, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8362904, | May 08 2007 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
8366614, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8372005, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8380273, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8391945, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8406835, | Apr 30 2004 | Koninklijke Philips Electronics N V | Probe head for spectroscopic analysis of a fluid |
8409131, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8456301, | May 08 2007 | ABBOTT DIABETES CARE, INC | Analyte monitoring system and methods |
8461985, | May 08 2007 | ABBOTT DIABETES CARE, INC | Analyte monitoring system and methods |
8465425, | Nov 01 2005 | Abbott Diabetes Care Inc | Analyte monitoring device and methods of use |
8467972, | Apr 28 2009 | Abbott Diabetes Care Inc | Closed loop blood glucose control algorithm analysis |
8471714, | May 17 2005 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
8473021, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8473220, | Jan 29 2009 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
8480580, | Apr 30 1998 | ABBOTT DIABETES CARE, INC | Analyte monitoring device and methods of use |
8504128, | Mar 08 2002 | GLT ACQUISITION CORP | Method and apparatus for coupling a channeled sample probe to tissue |
8512239, | Jun 10 2003 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
8512246, | Apr 28 2003 | Abbott Diabetes Care Inc. | Method and apparatus for providing peak detection circuitry for data communication systems |
8560082, | Jan 30 2009 | ABBOTT DIABETES CARE, INC | Computerized determination of insulin pump therapy parameters using real time and retrospective data processing |
8579853, | Oct 31 2006 | ABBOTT DIABETES CARE, INC | Infusion devices and methods |
8585591, | Nov 04 2005 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
8593109, | Mar 31 2006 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
8593287, | May 08 2007 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
8597189, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8597575, | Mar 31 2006 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
8612159, | Apr 30 1998 | Abbott Diabetes Care Inc | Analyte monitoring device and methods of use |
8617071, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8622903, | Dec 31 2002 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
8622906, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8638220, | Oct 31 2005 | Abbott Diabetes Care Inc. | Method and apparatus for providing data communication in data monitoring and management systems |
8641619, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8647269, | Jun 10 2003 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
8649841, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8652043, | Jan 02 2001 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8653977, | May 17 2005 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
8660627, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8664358, | Jun 29 2007 | ASPIRA WOMEN S HEALTH INC | Predictive markers for ovarian cancer |
8665091, | May 08 2007 | Abbott Diabetes Care Inc.; Abbott Diabetes Care Inc | Method and device for determining elapsed sensor life |
8666469, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8668645, | Jan 02 2001 | Abbott Diabetes Care Inc | Analyte monitoring device and methods of use |
8670815, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8672844, | Apr 30 1998 | Abbott Diabetes Care Inc | Analyte monitoring device and methods of use |
8676513, | Jan 29 2009 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
8688188, | Nov 01 2005 | Abbott Diabetes Care Inc | Analyte monitoring device and methods of use |
8718738, | Mar 08 2002 | GLT ACQUISITION CORP | Method and apparatus for coupling a sample probe with a sample site |
8732188, | Feb 18 2007 | ABBOTT DIABETES CARE, INC | Method and system for providing contextual based medication dosage determination |
8734346, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8734348, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8738109, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8744545, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8765059, | Apr 02 2001 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus |
8771183, | Dec 31 2002 | Abbott Diabetes Care Inc | Method and system for providing data communication in continuous glucose monitoring and management system |
8774887, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8798934, | Jul 23 2009 | Abbott Diabetes Care Inc.; Abbott Diabetes Care Inc | Real time management of data relating to physiological control of glucose levels |
8840553, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8868147, | Apr 28 2004 | GLT ACQUISITION CORP | Method and apparatus for controlling positioning of a noninvasive analyzer sample probe |
8870903, | Feb 21 2002 | GE HFS, LLC | Blood sampling device |
8880137, | Apr 30 1998 | Abbott Diabetes Care Inc | Analyte monitoring device and methods of use |
8915850, | Nov 01 2005 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8920319, | Nov 01 2005 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
8930203, | Feb 18 2007 | Abbott Diabetes Care Inc | Multi-function analyte test device and methods therefor |
8933664, | Mar 31 2006 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
8974386, | Apr 30 1998 | ABBOTT DIABETES CARE, INC | Analyte monitoring device and methods of use |
8993331, | Aug 31 2009 | Abbott Diabetes Care Inc | Analyte monitoring system and methods for managing power and noise |
9000929, | May 08 2007 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
9011331, | Apr 30 1998 | Abbott Diabetes Care Inc | Analyte monitoring device and methods of use |
9011332, | Jan 02 2001 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
9014773, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
9020573, | Nov 01 2005 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
9035767, | May 08 2007 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
9039975, | Mar 31 2006 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
9042953, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
9064107, | Oct 31 2006 | Abbott Diabetes Care Inc. | Infusion devices and methods |
9066694, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
9066695, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
9066697, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
9066709, | Jan 29 2009 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
9072477, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
9078607, | Nov 01 2005 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
9095290, | Mar 01 2007 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
9177456, | May 08 2007 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
9226701, | Apr 28 2009 | Abbott Diabetes Care Inc | Error detection in critical repeating data in a wireless sensor system |
9274118, | Jun 29 2007 | ASPIRA WOMEN S HEALTH INC | Predictive markers for ovarian cancer |
9314195, | Aug 31 2009 | Abbott Diabetes Care Inc | Analyte signal processing device and methods |
9314198, | May 08 2007 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
9320461, | Sep 29 2009 | Abbott Diabetes Care Inc | Method and apparatus for providing notification function in analyte monitoring systems |
9323898, | Nov 04 2005 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
9326714, | Apr 30 1998 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
9326716, | Nov 01 2005 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
9332944, | May 17 2005 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
9380971, | Mar 31 2006 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
9477811, | Apr 02 2001 | Abbott Diabetes Care Inc | Blood glucose tracking apparatus and methods |
9498159, | Jan 02 2001 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
9574914, | May 08 2007 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
9610034, | Jan 02 2001 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
9625413, | Mar 31 2006 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
9649057, | May 08 2007 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
9669162, | Nov 04 2005 | ABBOTT DIABETES CARE, INC | Method and system for providing basal profile modification in analyte monitoring and management systems |
9730584, | Jun 10 2003 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
9743863, | Mar 31 2006 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
9750439, | Sep 29 2009 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
9750440, | May 17 2005 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
9801545, | Mar 01 2007 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
9846158, | Jun 29 2007 | ASPIRA WOMEN S HEALTH INC | Predictive biomarkers for ovarian cancer |
9861317, | Feb 20 2014 | Covidien LP | Methods and systems for determining regional blood oxygen saturation |
9867561, | Jan 27 2014 | Covidien LP | Systems and methods for determining whether regional oximetry sensors are properly positioned |
9949678, | May 08 2007 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
9962091, | Dec 31 2002 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
9968302, | Aug 31 2009 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
9968306, | Sep 17 2012 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
9980669, | Nov 07 2011 | Abbott Diabetes Care Inc | Analyte monitoring device and methods |
9993201, | Apr 22 2015 | Samsung Electronics Co., Ltd. | Wearable device |
Patent | Priority | Assignee | Title |
4555179, | Nov 08 1982 | FIRMA G RODENSTOCK INSTRUMENTE GMBH | Detection and imaging of objects in scattering media by light irradiation |
5057695, | Dec 19 1988 | Otsuka Electronics Co., Ltd. | Method of and apparatus for measuring the inside information of substance with the use of light scattering |
5137355, | Jun 08 1988 | Research Foundation of State University of New York, The | Method of imaging a random medium |
5284149, | Jan 23 1992 | Method and apparatus for determining the physical characteristics of ocular tissue | |
5285783, | Feb 15 1990 | Koninklijke Philips Electronics N V | Sensor, apparatus and method for non-invasive measurement of oxygen saturation |
5517987, | Jun 02 1993 | Hamamatsu Photonics K.K. | Method for measuring internal information in scattering medium and apparatus for the same |
5596987, | Nov 02 1988 | NON-INVASIVE TECHNOLOGY, INCORPORATED | Optical coupler for in vivo examination of biological tissue |
5636637, | May 20 1994 | L Oreal | Method for determining quantities characteristic of the behavior of a surface, in particular of the human skin, subjected to light radiation, and apparatus for implementation thereof |
DE4314835, | |||
DE4414679, | |||
DE4417639, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Oct 28 1996 | ESSENPREIS, MATTHIAS | Boehringer Mannheim GmbH | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 008303 | /0968 | |
Oct 28 1996 | BOECKER, DIRK | Boehringer Mannheim GmbH | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 008303 | /0968 | |
Oct 31 1996 | KOHL, MATTHIAS | Boehringer Mannheim GmbH | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 008303 | /0968 | |
Oct 31 1996 | COPE, MARK | Boehringer Mannheim GmbH | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 008303 | /0968 | |
Nov 08 1996 | Boehringer Mannheim GmbH | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Dec 07 1998 | ASPN: Payor Number Assigned. |
Mar 28 2002 | M183: Payment of Maintenance Fee, 4th Year, Large Entity. |
Mar 28 2006 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Mar 23 2010 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Oct 20 2001 | 4 years fee payment window open |
Apr 20 2002 | 6 months grace period start (w surcharge) |
Oct 20 2002 | patent expiry (for year 4) |
Oct 20 2004 | 2 years to revive unintentionally abandoned end. (for year 4) |
Oct 20 2005 | 8 years fee payment window open |
Apr 20 2006 | 6 months grace period start (w surcharge) |
Oct 20 2006 | patent expiry (for year 8) |
Oct 20 2008 | 2 years to revive unintentionally abandoned end. (for year 8) |
Oct 20 2009 | 12 years fee payment window open |
Apr 20 2010 | 6 months grace period start (w surcharge) |
Oct 20 2010 | patent expiry (for year 12) |
Oct 20 2012 | 2 years to revive unintentionally abandoned end. (for year 12) |